AI may know how you’ll respond to a vaccine before you get it

Vaccines can elicit varying immune responses among individuals, according to a new study led by Arizona State University. The research suggests that certain antibody patterns in the blood before vaccination may predict how well someone will respond to a vaccine. Researchers examined blood samples from over 4,000 participants, measuring antibodies against 185 antigens, including common viruses, bacteria, and targets linked to autoimmune diseases.

Artificial intelligence was used to analyze the antibody signatures in samples taken before and after COVID-19 vaccination, identifying markers that distinguish strong responders from weaker ones. The findings could help tailor vaccination strategies to an individual's immune system. Certain "sentinel" antibodies present before vaccination, such as those targeting common microbes like Staphylococcus aureus, RSV, and human respirovirus 3, were associated with stronger COVID-19 vaccine responses.

These antibodies may indicate overall immune readiness, signaling a person's potential to mount a strong response to a vaccine. The study emphasizes the importance of considering the immune system as a whole rather than focusing on single biomarkers, and highlights the potential of AI and advanced blood testing in predicting vaccine responses and improving vaccine strategies.